Keryx Biopharmaceuticals has gotten CDMO Patheon approved by the FDA to produce its kidney drug Auryxia after earlier depleting supplies because of production…

The massive CPhI show kicked off in Barcelona, Spain, on Tuesday with numbers that rival some small cities. An estimated 38,000 visitors from 150 countries…

Finland’s Fermion plans to spend €30 million to expand an API plant in Hanko--its largest investment in company history--in a move to support current and…

An Irish contract manufacturer that once belonged to Stada, and which has changed hands several times in recent years, has ended up in liquidation, meaning…

U.S.-based AMRI has benefited from its buildup and focus on contract manufacturing and is now taking its strategy to Europe where it is making a deal that will…

Singapore’s monthly factory output numbers--a bellwether for the region’s economic health--got a big boost from the biomedical manufacturing sector.

Swedish CDMO Recipharm will get its first U.S. site with a deal to buy operations API and development operations from India’s Kemwell.

When Amgen CEO Robert Bradway announced big job cuts in 2014, he explained that part of the slimming would come from manufacturing its protein therapies more…

Outsourcing